Author:
STAALS L. M.,DRIESSEN J. J.,Van EGMOND J.,De BOER H. D.,KLIMEK M.,FLOCKTON E. A.,SNOECK M. M. J.
Subject
Anesthesiology and Pain Medicine,General Medicine
Reference39 articles.
1. A novel concept of reversing neuromuscular block;Bom;chemical encapsulation of rocuronium bromide by a cyclodextrin-based synthetic host,2002
2. Reversal of neuromuscular blockade and simultaneous increase in plasma rocuronium concentration after the intravenous infusion of the novel reversal agent Org 25969;Epemolu;Anesthesiology,2003
3. First human exposure of Org 25969, a novel agent to reverse the action of rocuronium bromide;Gijsenbergh;Anesthesiology,2005
4. Sugammadex, a selective reversal medication for preventing postoperative residual neuromuscular blockade;Abrishami;Cochrane Database Syst Rev,2009
5. Reversal of rocuronium-induced (1.2 mg/kg) profound neuromuscular block by sugammadex;De Boer;a multicenter, dose-finding and safety study,2007